Company Profile
Lipella Pharmaceuticals Stock Price, News & Catalysts
- Ticker:
- LIPO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 11, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for LIPO.
Company overview
Business overview
Lipella Pharmaceuticals is a specialty pharmaceutical company focused on localized therapies for difficult urologic and inflammatory conditions. Its story is built around reformulating existing drugs for targeted delivery.
Geographic Base and Sector Classification
Lipella is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and drug-delivery development.
Business Model Characteristics
The company depends on clinical development, regulatory progress, and the ability to create value through localized formulations. Investors usually watch data updates and pipeline execution.
Position Within the Biotechnology Landscape
Lipella occupies a narrow specialty-pharma niche within biotech. It is a formulation story where better delivery could matter as much as the active ingredient.
Future catalysts
- Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible. The company still needs human proof.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lipella Pharmaceuticals (LIPO)?
Lipella Pharmaceuticals (LIPO) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Lipella Pharmaceuticals do?
Lipella Pharmaceuticals is a specialty pharmaceutical company focused on localized therapies for difficult urologic and inflammatory conditions. Its story is built around reformulating existing drugs for targeted delivery.
On which exchange is LIPO stock listed?
Lipella Pharmaceuticals (LIPO) is associated with NASDAQ, United States, Biopharma.
What is Lipella?
Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible.
Which conditions is Lipella Pharmaceuticals targeting with Lipella?
Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible.
How does Lipella Pharmaceuticals describe recent progress with Lipella?
Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible.
What is Pharmaceuticals?
Lipella Pharmaceuticals is a specialty pharmaceutical company focused on localized therapies for difficult urologic and inflammatory conditions.
What should investors watch for with Pharmaceuticals?
Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible. The company still needs human proof.